疏郁通降方对反流性食管炎肝胃郁热证患者胃肠激素的影响OA
The Influence of Shuyu Tongjiang Formula on Gastrointestinal Hormones in the Patients of Reflux Esophagitis with Syndrome of Heat Stagnation in Liver-Stomach
目的:探究疏郁通降方协同奥美拉唑对反流性食管炎肝胃郁热证的临床治疗及其对胃肠激素的影响.方法:选取中国药科大学附属浦口中医院、南京市中西医结合医院两家医疗机构消化科门诊的反流性食管炎肝胃郁热证患者,依据随机数字表随机分为观察组和对照组,每组各42例.对照组给予奥美拉唑肠溶胶囊治疗,观察组在对照组治疗基础上加用疏郁通降方,两组均治疗8周.比较两组治疗前后反流性疾病问卷(RDQ)评分、胃食管反流病相关生活质量量表(GERD-HRQL)评分以及血清学指标的变化情况,并比较内镜疗效、中医证候疗效和远期疗效.结果:治疗后,两组RDQ 评分和GERD-HRQL评分均显著下降(P<0.01),且观察组下降幅度明显高于对照组(P<0.01).观察组内镜治疗有效率为97.62%(41/42),对照组为90.48%(38/42),观察组高于对照组,但两组比较差异无统计学意义(P>0.05).观察组中医证候疗效有效率97.62%(41/42),对照组83.33%(35/42),两组比较差异有统计学意义(P<0.01).治疗后,两组胃动素、胃泌素水平均显著高于治疗前(P<0.01),且观察组高于对照组(P<0.01).随访结果显示,观察组、对照组症状复发率分别为5.6%、25.8%,两组比较差异有统计学意义(P<0.05).结论:疏郁通降方联合奥美拉唑能有效减轻反流症状,改善肝胃郁热证相关症状表现,可以修复食管炎症损伤,改善生存质量,降低复发率.
Objective:To evaluate the clinical efficacy of Shuyu Tongjiang Formula combined with Omeprazole for reflux esophagitis(RE)with syndrome of heat stagnation in liver-stomach and influence of gastrointestinal hormones.Methods:In this randomized controlled trial,patients of RE with syndrome of heat stagnation in liver-stomach from gastroenterology clinics of Pukou Traditional Chinese Medicine Hospital Affiliated to China Pharmaceutical University and Nanjing Integrated Traditional Chinese and Western Medicine Hospital were selected,and were randomly divided into an observation group and a control group according to a random number table,42 patients for each one.The control group received the treatment of Omeprazole enteric-coated capsules,while the observation group received Shuyu Tongjiang Formula on the basis of control group.Both group underwent 8 weeks of treatment.Outcomes included Reflux Disease Questionnaire(RDQ)scores,Gastroesophageal Reflux Disease-Health-Related Quality of Life(GERD-HRQL)scores,and the changes of serum markers were compared,as well as the endoscopic efficacy,traditional Chinese medicine(TCM)syndrome efficacy and long-term effect.Results:After treatment,the RDQ and GERD-HRQL scores were significantly decreased(P<0.01),while the magnitude of the reduction was significantly greater in the observation group than in the control group(P<0.01).Endoscopic efficacy rates were 97.62%(41/42)in observation group,while 90.48%(35/42)in control group,the difference between the two groups was not statistically significant(P>0.05).TCM syndrome efficacy in observation group was 97.62%(41/42),while the control group was 83.33%(35/42),the difference between the two groups was statistically significant(P<0.01).After treatment,the levels of motilin and gastrin in both groups were significantly higher than those before treatment(P<0.01),and the levels in the observation group were higher than those in the control group(P<0.01).According to the follow-up,the symptom recurrence rates in the observation group and the control group were 5.6%and 25.8%respectively(P<0.05),the difference was statistically significant.Conclusion:The combination of Shuyu Tongjiang Formula and Omeprazole demonstrated significant efficacy in alleviating RE symptoms,improving syndrome of heat stagnation in liver-stomach,promoting the healing of esophageal inflammation,enhancing the quality of life,and reducing the symptom recurrence rate.
YANG Lu;SU Kunhan;WU Hao;ZHANG Yue;LIU Wanli
Pukou Traditional Chinese Medicine Hospital Affiliated to China Pharmaceutical University,Nanjing 211899,ChinaNanjing Integrated Traditional Chinese and Western Medicine Hospital,Nanjing 210014,ChinaNanjing Integrated Traditional Chinese and Western Medicine Hospital,Nanjing 210014,ChinaPukou Traditional Chinese Medicine Hospital Affiliated to China Pharmaceutical University,Nanjing 211899,ChinaNanjing First Hospital,Nanjing Medical University,Nanjing 210006,China
疏郁通降方反流性食管炎肝胃郁热证疗效评价
Shuyu Tongjiang FormulaReflux esophagitisHeat stagnation in liver-stomachEfficacy evaluation
《中医药信息》 2026 (1)
47-52,6
国家自然科学基金面上项目(82174125)江苏省第三批中医药领军人才项目(SLJ0308)南京市卫生科技发展专项资金项目(YKK22189)南京市医疗机构中药传统制剂备案研究项目(NJCC-ZJ-202325)
评论